Literature DB >> 16495695

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma.

Min-Shan Chen1, Jin-Qing Li, Yun Zheng, Rong-Ping Guo, Hui-Hong Liang, Ya-Qi Zhang, Xiao-Jun Lin, Wan Y Lau.   

Abstract

OBJECTIVE: To compare the results of percutaneous local ablative therapy (PLAT) with surgical resection in the treatment of solitary and small hepatocellular carcinoma (HCC). SUMMARY BACKGROUND DATA: PLAT is effective in small HCC. Whether it is as effective as surgical resection in the long-term survivals remains unknown.
METHODS: We conducted a prospective randomized trial on 180 patients with a solitary HCC <or=5 cm to receive either PLAT or surgical resection. The patients were regularly followed up after treatment with physical examination, blood, and radiologic tests.
RESULTS: Of the 90 patients who were randomized to PLAT, only 71 received PLAT because 19 withdrew their consent. Of the 90 patients who were randomized to surgical resection, a single Couinaud liver segment resection was carried out in 69 patients, 2 segments in 16 patients, and 3 or more segments in 3 patients. Ethanol injection was given during open surgery in 2 patients. Only 1 patient died after surgical resection within the same hospital admission. Posttreatment complications were more often and severe after surgery than PLAT. The 1-, 2-, 3-, and 4-year overall survival rates after PLAT and surgery were 95.8%, 82.1%, 71.4%, 67.9% and 93.3%, 82.3%, 73.4%, 64.0%, respectively. The corresponding disease-free survival rates were 85.9%, 69.3%, 64.1%, 46.4% and 86.6%, 76.8%, 69%, 51.6%, respectively. Statistically, there was no difference between these 2 treatments.
CONCLUSION: PLAT was as effective as surgical resection in the treatment of solitary and small HCC. PLAT had the advantage over surgical resection in being less invasive.

Entities:  

Mesh:

Year:  2006        PMID: 16495695      PMCID: PMC1448947          DOI: 10.1097/01.sla.0000201480.65519.b8

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.

Authors:  N Nicoli; A Casaril; L Marchiori; G Mangiante; G Marini; R Colombari; A Portuese; A R Hasheminia
Journal:  Chir Ital       Date:  2000 Jan-Feb

3.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

4.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.

Authors:  L Buscarini; E Buscarini; M Di Stasi; D Vallisa; P Quaretti; A Rocca
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

5.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

7.  Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.

Authors:  J Yamamoto; S Okada; K Shimada; T Okusaka; S Yamasaki; H Ueno; T Kosuge
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 8.  Management of hepatocellular carcinoma.

Authors:  W Y Lau
Journal:  J R Coll Surg Edinb       Date:  2002-02

Review 9.  Epidemiology of primary liver cancer.

Authors:  F X Bosch; J Ribes; J Borràs
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 10.  Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.

Authors:  W Y Lau; Thomas W T Leung; Simon C H Yu; Stephen K W Ho
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more
  394 in total

1.  A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yuzo Umeda; Hiroaki Matsuda; Hiroshi Sadamori; Hiroyoshi Matsukawa; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 2.  Complications after percutaneous ablation of liver tumors: a systematic review.

Authors:  Eylon Lahat; Rony Eshkenazy; Alex Zendel; Barak Bar Zakai; Mayan Maor; Yael Dreznik; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

3.  A special recurrent pattern in small hepatocellular carcinoma after treatment: bile duct tumor thrombus formation.

Authors:  Qing-Yu Liu; Dong-Ming Lai; Chao Liu; Lei Zhang; Wei-Dong Zhang; Hai-Gang Li; Ming Gao
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

4.  A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Noboru Tanigawa; Shuji Kariya; Hiroki Ikeda; Yoshitsugu Nakahashi; Junko Hirohara; Chizu Koreeda; Toshihito Seki; Satoshi Sawada; Kazuichi Okazaki; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

5.  Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.

Authors:  M Sherman; K Burak; J Maroun; P Metrakos; J J Knox; R P Myers; M Guindi; G Porter; J R Kachura; P Rasuli; S Gill; P Ghali; P Chaudhury; J Siddiqui; D Valenti; A Weiss; R Wong
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

6.  Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study.

Authors:  Wei-Xing Guo; Bo Zhai; Eric C H Lai; Nan Li; Jie Shi; Wan-Yee Lau; Meng-Chao Wu; Shu-Qun Cheng
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

7.  Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.

Authors:  Dong Ho Lee; Jeong Min Lee; Mi Hye Yu; Bo Yun Hur; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Jung-Hwan Yoon; Yoon Jun Kim; Jeong-Hoon Lee; Su Jong Yu; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-01-14       Impact factor: 5.315

8.  Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Alessandro Valdegamberi; Silvia Pachera; Tommaso Campagnaro; Mirko D'Onofrio; Enrico Martone; Paola Nicoli; Calogero Iacono
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

Review 9.  The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma--indication, technique and results.

Authors:  Till Herbold; Roger Wahba; Christopher Bangard; Münevver Demir; Uta Drebber; Dirk L Stippel
Journal:  Langenbecks Arch Surg       Date:  2012-10-24       Impact factor: 3.445

Review 10.  Radiofrequency ablation of liver tumors.

Authors:  Shaunagh McDermott; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.